SeaStar Medical Holding Corp

SeaStar Medical Holding Corp, trading under the ticker LMAO on Nasdaq, is the surviving entity formed through the business combination of blank-check company LMF Acquisition Opportunities, Inc. and SeaStar Medical, Inc., a medical-device company focused on the Selective Cytopheretic Device for acute kidney injury treatment. LMF Acquisition Opportunities was sponsored by LMF Acquisition Sponsor, LLC, an affiliate of LM Funding America. The SPAC completed its initial public offering in 2021 and targets the healthcare and medical-technology sector. This 8-K, filed April 26, 2022, reflects a material event disclosure during the transaction process. Sign up at SpacDesk for full filing history, sponsor details, and real-time deal-status data on LMAO and hundreds of other SPACs.